On August 2, 2023, VLP Therapeutics, Inc. closed the transaction. The company announced that it has received a round of funding. The transaction included participation from new investors, YMC CO., LTD., The Research Foundation For Microbial Diseases of Osaka University, Toyo Ink SC Holdings Co., Ltd. and returning investor, Sojitz Corporation.

The company raised the funding at a post-money valuation of $86,913,042.